<DOC>
	<DOCNO>NCT02400151</DOCNO>
	<brief_summary>The main objective study analyze population obese adolescent , effect vitamin D3 supplementation addition lifestyle dietary management vascular function assess change M0 M3 endothelium-dependent vasorelaxation measure brachial artery ( Flow-Mediated Dilation ) .</brief_summary>
	<brief_title>Vascular Metabolic Effects Vitamin D Supplementation Associated With Lifestyle Management Obese Adolescents</brief_title>
	<detailed_description>The secondary objective study : A . To analyze obese adolescent , effect addition vitamin D3 supplementation metabolic vascular function . B . To compare relationship food intake , metabolic , inflammatory , oxidative stress vitamin D status , vascular dysfunction obese normal weight subject . C. To evaluate effect sun exposure variation relationship describe Objective B compare observed parameter baseline end three month follow-up period , non-supplemented obese adolescent adolescent normal weight . D. To identify biomarkers ( metabolic signature ) obese adolescent associate vitamin D deficiency vascular function . E. To evaluate obese adolescent , effect vitamin D supplementation metabolome ( metabolic signature ) . F. To evaluate effect lifestyle dietary management biomarkers ( `` control group '' ) . For target ( A F ) , teenager classify accord three level skin pigmentation . G. Establish biobank sample take baseline 3 month .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>General The patient 's legal representative must give inform sign consent The patient must insure beneficiary health insurance plan Sexual maturation least Tanner stage 2 Inclusion criterion patient population The subject body mass index correspond grade 2 obesity accord curve describe RollandCachera et al ( 1991 ) Absence least 5 % total weight last 3 month Inclusion criterion control population The subject body mass index &lt; 90th percentile The patient participate another study The patient exclusion period determine previous study The patient judicial protection The patient 's legal representative ( ) refuse ( ) sign consent It impossible correctly inform patient his/her legal representative ( ) The patient contraindication physical activity ( joint , heart ) The subject least 3 hour extracurricular physical activity per week The subject concomitant illness , history firstdegree cardiovascular disease , abnormal glucose tolerance ( prediabetes diabetes ) . Active smoking Known dyslipidemia ( particularly hypercholesterolemia ) . The subject regularly take food vitamin supplement refuse stop take study ( case disruption supplement , washout stop period 3 week require ) . BMI correspond grade 1 obesity accord RollandCachera et al . ( 1991 ) curve . Secondary know genetic obesity . Known hypersensitivity vitamin D. Hypercalcemia , hypercalciuria , calcium lithiasis</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>